vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and WEST BANCORPORATION INC (WTBA). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $26.9M, roughly 1.2× WEST BANCORPORATION INC). WEST BANCORPORATION INC runs the higher net margin — 39.2% vs -32.1%, a 71.4% gap on every dollar of revenue. On growth, WEST BANCORPORATION INC posted the faster year-over-year revenue change (16.6% vs -4.5%). WEST BANCORPORATION INC produced more free cash flow last quarter ($12.4M vs $25.0K). Over the past eight quarters, WEST BANCORPORATION INC's revenue compounded faster (17.3% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
West Bancorporation Inc. is a regional financial holding company headquartered in the U.S. Midwest, primarily serving markets across Iowa and Minnesota. It provides a full suite of personal and commercial banking services, including deposit accounts, mortgage loans, business lending, and wealth management solutions for individual consumers, small-to-medium enterprises, and local organizational clients.
LFCR vs WTBA — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $26.9M |
| Net Profit | $-10.0M | $10.6M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 50.0% |
| Net Margin | -32.1% | 39.2% |
| Revenue YoY | -4.5% | 16.6% |
| Net Profit YoY | -52.0% | 34.8% |
| EPS (diluted) | $-0.29 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $26.9M | ||
| Q4 25 | — | $24.2M | ||
| Q3 25 | $31.1M | $25.0M | ||
| Q2 25 | — | $23.8M | ||
| Q1 25 | $35.2M | $23.1M | ||
| Q4 24 | $32.6M | $20.9M | ||
| Q3 24 | $24.7M | $20.3M | ||
| Q2 24 | — | $19.6M |
| Q1 26 | — | $10.6M | ||
| Q4 25 | — | $7.4M | ||
| Q3 25 | $-10.0M | $9.3M | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | $-14.8M | $7.8M | ||
| Q4 24 | $-6.6M | $7.1M | ||
| Q3 24 | $-16.2M | $6.0M | ||
| Q2 24 | — | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | 50.0% | ||
| Q4 25 | — | 39.6% | ||
| Q3 25 | -9.9% | 45.8% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | -25.7% | 43.4% | ||
| Q4 24 | -6.0% | 30.9% | ||
| Q3 24 | -46.9% | 36.6% | ||
| Q2 24 | — | 32.6% |
| Q1 26 | — | 39.2% | ||
| Q4 25 | — | 30.7% | ||
| Q3 25 | -32.1% | 37.3% | ||
| Q2 25 | — | 33.5% | ||
| Q1 25 | -42.0% | 34.0% | ||
| Q4 24 | -20.2% | 34.0% | ||
| Q3 24 | -65.7% | 29.3% | ||
| Q2 24 | — | 26.5% |
| Q1 26 | — | $0.61 | ||
| Q4 25 | — | $0.44 | ||
| Q3 25 | $-0.29 | $0.55 | ||
| Q2 25 | — | $0.47 | ||
| Q1 25 | $-0.47 | $0.46 | ||
| Q4 24 | $-0.25 | $0.41 | ||
| Q3 24 | $-0.53 | $0.35 | ||
| Q2 24 | — | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $362.0M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $270.7M |
| Total Assets | $235.2M | $4.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $362.0M | ||
| Q4 25 | — | $471.1M | ||
| Q3 25 | $18.9M | $232.9M | ||
| Q2 25 | — | $345.2M | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $9.5M | $243.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $270.7M | ||
| Q4 25 | — | $266.0M | ||
| Q3 25 | $-10.5M | $255.1M | ||
| Q2 25 | — | $240.9M | ||
| Q1 25 | $2.2M | $237.9M | ||
| Q4 24 | $15.4M | $227.9M | ||
| Q3 24 | $-3.9M | $235.4M | ||
| Q2 24 | — | $223.9M |
| Q1 26 | — | $4.0B | ||
| Q4 25 | — | $4.1B | ||
| Q3 25 | $235.2M | $4.0B | ||
| Q2 25 | — | $4.1B | ||
| Q1 25 | $237.7M | $4.0B | ||
| Q4 24 | $255.4M | $4.0B | ||
| Q3 24 | $246.8M | $4.0B | ||
| Q2 24 | — | $4.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $12.9M |
| Free Cash FlowOCF − Capex | $25.0K | $12.4M |
| FCF MarginFCF / Revenue | 0.1% | 46.0% |
| Capex IntensityCapex / Revenue | 5.6% | 1.8% |
| Cash ConversionOCF / Net Profit | — | 1.22× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $79.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $12.9M | ||
| Q4 25 | — | $46.5M | ||
| Q3 25 | $1.8M | $11.4M | ||
| Q2 25 | — | $13.5M | ||
| Q1 25 | $1.2M | $9.7M | ||
| Q4 24 | $-6.1M | $39.8M | ||
| Q3 24 | $-613.0K | $12.9M | ||
| Q2 24 | — | $10.0M |
| Q1 26 | — | $12.4M | ||
| Q4 25 | — | $43.2M | ||
| Q3 25 | $25.0K | $10.8M | ||
| Q2 25 | — | $12.8M | ||
| Q1 25 | $-4.3M | $8.3M | ||
| Q4 24 | $-8.6M | $13.7M | ||
| Q3 24 | $-4.0M | $7.0M | ||
| Q2 24 | — | $2.7M |
| Q1 26 | — | 46.0% | ||
| Q4 25 | — | 178.3% | ||
| Q3 25 | 0.1% | 43.0% | ||
| Q2 25 | — | 53.6% | ||
| Q1 25 | -12.1% | 35.7% | ||
| Q4 24 | -26.3% | 65.6% | ||
| Q3 24 | -16.3% | 34.2% | ||
| Q2 24 | — | 14.0% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | — | 13.7% | ||
| Q3 25 | 5.6% | 2.6% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | 15.5% | 6.5% | ||
| Q4 24 | 7.5% | 125.3% | ||
| Q3 24 | 13.9% | 29.4% | ||
| Q2 24 | — | 37.1% |
| Q1 26 | — | 1.22× | ||
| Q4 25 | — | 6.26× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.70× | ||
| Q1 25 | — | 1.24× | ||
| Q4 24 | — | 5.61× | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | — | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
WTBA
Segment breakdown not available.
